Architect i2000sr immune analyze system

Manufactured by Abbott

The ARCHITECT i2000SR is an automated immune analyzer system designed for clinical laboratories. It performs immunoassay tests to detect and measure the presence of various substances in biological samples. The system utilizes chemiluminescent microparticle immunoassay (CMIA) technology to provide accurate and reliable results.

Automatically generated - may contain errors

Lab products found in correlation

Elecsys 2010, by Roche (1 mentions) Eclia kit, by Roche (1 mentions) Hdl c, by Fujifilm (1 mentions) Ldl c, by Fujifilm (1 mentions) C reactive protein (crp), by Fujifilm (1 mentions) Labospect 008, by Hitachi (1 mentions)

2 protocols using architect i2000sr immune analyze system

Serum Biomarker Panel Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols

We detected a panel of five biomarkers, namely CA125, CEA, NSE, Cyfra21-1and SCC. The serum levels of CEA, CA125, NSE and Cyfra21-1 were tested by electrochemiluminescence immunoassay (ECLIA) kits using Elecsys 2010 (Roche, America). The levels of SCC in the serum were detected by SCC assay kit using an ARCHITECT I2000SR immune analyze system (Abbott, America). Each test included a standard control (CV < 5%).

Wang X., Zhi X., Yang Z., Tian H., Li Y., Li M., Zhao W., Zhang C., Wang T., Liu J., Shen D., Zheng C., Zhao D., Yang S., Qi J., Xin H., Stojadinovic A., Avital I., Lee L.J., Rao J, & Zhang W. (2017). A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT). Oncotarget, 8(28), 45345-45355.

+ Open protocol

+ Expand

Comprehensive Biomarker Analysis in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols

The concentrations of CEA and CYFRA211 in the plasma were assessed using electrochemiluminescence immunoassay (ECLIA) kits (Roche, Germany) on a Roche E170 fully automatic electrochemistry luminescence immunity analyzer (Roche, German). The levels of SCCA in the plasma were detected using an ARCHITECT I2000SR immune analyze system (Abbott, America). Each test included a standard control (CV < 5%).
The plasma biochemical indices including TG, CHO, HDL-C, LDL-C(WAKO, Japan), ApoA1, Apo-B(Maccura,China) and inflammatory biomarker CRP (WAKO, Japan) were measured on an automatic biochemical analyzer (LABOSPECT 008; Hitachi HighTechnologies Corporation, Japan).
The plasma hemostasis indices including PT, APTT, FBG, TT, DD (Siemens, Germany) and FDP (BIOLINKS CO., LTD, Japan) were measured on an automatic coagulation analyzer (SYSMEX CS-5100 Hemostasis System, Japan). PT% and INR were calculated according to the formula recommended by the manufacture’s instruction.

Liao Y., Xing S., Xu B., Liu W, & Zhang G. (2017). Evaluation of the circulating level of fibroblast activation protein α for diagnosis of esophageal squamous cell carcinoma. Oncotarget, 8(18), 30050-30062.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!